Unlock stock picks and a broker-level newsfeed that powers Wall Street.
17.10
-1.60
(-8.56%)
At close: April 4 at 9:48:28 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-582,453
-582,453
-331,725
-297,689
-145,840
Investing Cash Flow
-244,974
-244,974
129,830
-304,790
944
Financing Cash Flow
677,774
677,774
211,908
767,597
138,447
End Cash Position
102,542
102,542
252,120
242,604
77,057
Income Tax Paid Supplemental Data
--
--
--
38,165
16,594
Interest Paid Supplemental Data
125
125
--
--
107
Capital Expenditure
-4,049
-4,049
-3,048
-41,074
-938
Issuance of Capital Stock
666,165
666,165
243,225
283,804
--
Free Cash Flow
-586,502
-586,502
-334,773
-338,763
-146,778
12/31/2021 - 9/29/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
5KW.F SkinBioTherapeutics plc
0.2620
-6.43%
HQ1.MU Oruka Therapeutics Inc. R
8.25
-6.25%
2HA.MU Spero Therapeutics Inc
0.5750
-10.99%
HPHA.F Heidelberg Pharma AG
2.6500
-6.03%
22Z.SG Zealand Pharma A/S
58.30
-6.65%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.3040
-1.62%
05Y.F Vivoryon Therapeutics N.V.
1.7460
+0.92%
NP5.F Newron Pharmaceuticals S.p.A.
6.32
-10.99%
ASCLF Ascletis Pharma Inc.
1.2000
0.00%
NKB2.F TG Therapeutics, Inc.
35.07
-1.21%